BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 12390328)

  • 1. The sodium iodide symporter: its pathophysiological and therapeutic implications.
    Spitzweg C; Morris JC
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].
    Spitzweg C
    Internist (Berl); 2003 Apr; 44(4):396-402, 404-8, 410-1. PubMed ID: 12914397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The practical relevance of the sodium iodide symporter].
    Spitzweg C
    Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective view of sodium iodide symporter research and its clinical implications.
    Riesco-Eizaguirre G; Santisteban P
    Eur J Endocrinol; 2006 Oct; 155(4):495-512. PubMed ID: 16990649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
    Heufelder AE; Morgenthaler N; Schipper ML; Joba W
    Thyroid; 2001 Sep; 11(9):839-47. PubMed ID: 11575853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium iodide symporter: its role in nuclear medicine.
    Chung JK
    J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Na(+)/I(-) symporter (NIS) research in the thyroid and beyond.
    Dohán O; Carrasco N
    Mol Cell Endocrinol; 2003 Dec; 213(1):59-70. PubMed ID: 15062574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sodium-iodine symporter in thyroid, normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment].
    Foujilas C; Marakaki C; Syrmos N
    Hell J Nucl Med; 2009; 12(2):189-93. PubMed ID: 19675882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
    Berger F; Unterholzner S; Diebold J; Knesewitsch P; Hahn K; Spitzweg C
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1258-63. PubMed ID: 16982034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
    Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
    J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of sodium-iodide importer (NIS) between lactating breast and thyroid tissues may be due to structural difference of thyroid-stimulating hormone receptor (TSHR).
    Shi XZ; Xue L; Jin X; Xu P; Jia S; Shen HM
    J Endocrinol Invest; 2017 Jan; 40(1):41-48. PubMed ID: 27531173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of sodium iodide symporter identifies aggressive thyroid tumors.
    Ward LS; Santarosa PL; Granja F; da Assumpção LV; Savoldi M; Goldman GH
    Cancer Lett; 2003 Oct; 200(1):85-91. PubMed ID: 14550956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
    Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
    Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sodium-iodide symporter.
    Baker CH; Morris JC
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):167-74. PubMed ID: 15379719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sodium/iodide symporter: state of the art of its molecular characterization.
    Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.
    De La Vieja A; Dohan O; Levy O; Carrasco N
    Physiol Rev; 2000 Jul; 80(3):1083-105. PubMed ID: 10893432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.
    Ravera S; Reyna-Neyra A; Ferrandino G; Amzel LM; Carrasco N
    Annu Rev Physiol; 2017 Feb; 79():261-289. PubMed ID: 28192058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
    Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
    Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.